Yaohai Bio-Pharma, a contract research, development and manufacturing organization (CRDMO) that specializes in microbial expression systems, announced today that it will exhibit at TIDES Europe 2026. The event will take place November 3–5, 2026 at RAI Amsterdam in Amsterdam, Netherlands. Attendees are invited to visit Booth 904 to meet the Yaohai team, learn about full-lifecycle development and manufacturing solutions, and receive a special gift prepared for conference guests.
At TIDES Europe 2026, Yaohai Bio-Pharma will highlight its integrated service offerings. These include recombinant proteins, nucleic acid drugs, nanobodies, plasmid DNA, and innovative vaccines. In addition, the company supports global partners from early research and process development all the way to cGMP manufacturing and commercial supply. As a result, partners can move programs forward with scalable, regulatory-ready microbial expression platforms.
Moreover, Yaohai Bio-Pharma encourages attendees to schedule a dedicated meeting in advance. The company’s scientific and business development teams will be available at Booth 904 to discuss project requirements, technical challenges, and tailored CRO/CDMO/MAH solutions. To book a meeting, please contact us through the company website or reach out to your Yaohai Bio-Pharma representative.
Furthermore, visitors to Booth 904 can also pick up an exclusive Yaohai Bio-Pharma gift. This gift is prepared as a token of appreciation for the global oligonucleotide and peptide community. However, quantities are limited and will be available while supplies last.
For more information about Yaohai Bio-Pharma’s services, or to schedule a meeting at TIDES Europe 2026, please visit our website and contact our business development team.
About TIDES Europe
TIDES Europe 2026 is a key industry event for oligonucleotide and peptide professionals. It brings together scientists, developers, and manufacturers from across the nucleic acid and peptide therapeutics fields. The event covers the full development journey, from early discovery and chemistry to manufacturing and regulatory strategy.
About Yaohai Bio-Pharma
Yaohai Bio-Pharma is a CRDMO with extensive expertise in microbial expression systems. We focus on recombinant proteins, nucleic acid drugs, nanobodies, plasmid DNA, and innovative vaccines. From R&D to commercial manufacturing, we offer full-lifecycle solutions. Our mission is to build an open, integrated CRO/CDMO/MAH platform that supports global partners from discovery to market.
